Skip to main content
OpenTrials
Completed

NCT Number: NCT03663192

Strain Echocardiography During Septic Shock : an Observational Pilot Study

The mortality of septic shock remains high nowadays despite a trend toward improvement.Septic cardiomyopathy has been reported in most experimental models of sepsis shock. Its relationship with mortality is unclear. A decrease in mortality have been reported in patients with decreased left ventricular ejection fraction (LVEF), but a recent meta-analysis did not support such results. In fact, it appears that high LVEF are linked to profound vasoplegia which is associated to bad outcome.

In the other hand, alterations of Strain echocardiography, a new method allowing a more sensitive evaluation of heart function, have been associated with a worse outcome in sepsis patients. Only few studies have examined echocardiographic strain during sepsis shock in human, and its natural history was only described in pigs. Moreover, the right ventricular strain was reported only by Orde et al whereas the evolution of strain during fluid infusion have never been studied. The aim of the present study is to describe the natural history of echocardiographic strain during sepsis shock and to determine its prognosis value.

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Intensive care unit CHU Nimes

Nîmes, 30029, France

Who can participate

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Septic shock (suspected or proven infection and norepinephrine ≥ 0,25µg/kg/min)
  • Inclusion within the first 24h of septic shock

Exclusion criteria

  • Patient < 18 year of age
  • Pregnant women
  • History of myocardial infarction, valvular disease, atrial fibrillation

Treatment and study plan

strain echocardiography

Device

strain echocardiography during septic shock

Primary outcomes

  1. Global peak systolic longitudinal strain assessed by echocardiography. Global peak systolic longitudinal strain

    Time frame: up to 90 days

Secondary outcomes

  1. ICU mortality

    Time frame: up to 90 days

    On the day of patient discharge from the ICU

Sponsors and collaborators

Lead sponsor

Centre Hospitalier Universitaire de Nīmes

Other

Registry information

Acronym: Sepsistrain

Important dates

Study start
2016
Primary completion
2018
Study completion
2018
First posted
Sep 10, 2018
Registry last updated
Dec 1, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.